These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7241047)

  • 1. Human complement in the arachidonic acid transformation pathway in platelets.
    Polley MJ; Nachman RL; Weksler BB
    J Exp Med; 1981 Feb; 153(2):257-68. PubMed ID: 7241047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex.
    Polley MJ; Nachman RL
    J Exp Med; 1979 Sep; 150(3):633-45. PubMed ID: 479764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane B2 synthesis in human platelets induced by the late complement components C5b-9.
    Betz M; Seitz M; Hänsch GM
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):313-6. PubMed ID: 2437045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages release arachidonic acid, prostaglandin E2, and thromboxane in response to late complement components.
    Hänsch GM; Seitz M; Martinotti G; Betz M; Rauterberg EW; Gemsa D
    J Immunol; 1984 Oct; 133(4):2145-50. PubMed ID: 6432907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretion of the terminal complement proteins, C5-C9, by human platelets.
    Houle JJ; Leddy JP; Rosenfeld SI
    Clin Immunol Immunopathol; 1989 Mar; 50(3):385-93. PubMed ID: 2917425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human platelet-initiated formation and uptake of the C5-9 complex of human complement.
    Zimmerman TS; Kolb WP
    J Clin Invest; 1976 Jan; 57(1):203-11. PubMed ID: 812888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
    Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
    J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3.
    Kitamura H; Matsumoto M; Nagaki K
    Immunology; 1984 Nov; 53(3):575-82. PubMed ID: 6237987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
    Joiner KA; Hammer CH; Brown EJ; Frank MM
    J Exp Med; 1982 Mar; 155(3):809-19. PubMed ID: 6801180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of the membrane attack mechanism of complement.
    Kolb WP; Haxby JA; Arroyave CM; Müller-Eberhard HJ
    J Exp Med; 1972 Mar; 135(3):549-66. PubMed ID: 5058233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
    Kitamura H; Tsuboi M; Nagaki K
    Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets.
    Dixon RH; Rosse WF
    J Clin Invest; 1977 Feb; 59(2):360-8. PubMed ID: 833281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human complement system in thrombin-mediated platelet function.
    Polley MJ; Nachman R
    J Exp Med; 1978 Jun; 147(6):1713-26. PubMed ID: 681879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical analyses of membrane-bound complement. Detection of the terminal complement complex and its similarity to "intrinsic" erythrocyte membrane proteins.
    Bhakdi S; Bjerrum OJ; Rother U; Knüfermann H; Wallach DF
    Biochim Biophys Acta; 1975 Sep; 406(1):21-35. PubMed ID: 809065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
    Stewart JL; Kolb WP; Sodetz JM
    J Immunol; 1987 Sep; 139(6):1960-4. PubMed ID: 3624872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b,6,7 complex into phospholipid bilayers of erythrocyte membranes.
    Hammer CH; Nicholson A; Mayer MM
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):5076-80. PubMed ID: 1061092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
    Podack ER; Tschoop J; Müller-Eberhard HJ
    J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.